Outstanding Clinical Outcomes

Platinum Chromium Everolimus-Eluting Clinical Experience

Excellent Safety and Performance with Promus PtCr EES1

  • Over 10,000 Patients Studied
  • Over 1 Million Implants

The Promus PREMIERTM Stent is the newest member of the PROMUSTM family, featuring the same low dose Everolimus drug and PVDF-HFP polymer combined with the exceptional Platinum Chromium platform. The PLATINUM Clinical Trial Program is the basis for the Promus PREMIER Stent System approval.